Dược Động Học :
▧ Absorption :
Rapidly absorbed after intramuscular injection and peak plasma levels are reached in 20-40 minutes. The absolute bioavailability is 60-70% and is unchanged in patients with allergic rhinitis. In patients using a nasal vasoconstrictor (oxymetazoline) the fraction of the dose absorbed was unchanged, but the rate of absorption was slowed. Oral bioavailability is only 5-17% because of extensive first-pass metabolism.
▧ Volume of Distribution :
* 305 to 901 L
▧ Protein binding :
Serum protein binding is approximately 80%.
▧ Metabolism :
Extensively metabolized in the liver. The pharmacological activity of butorphanol metabolites has not been studied in humans; in animal studies, butorphanol metabolites have demonstrated some analgesic activity.
▧ Route of Elimination :
Butorphanol is extensively metabolized in the liver. Elimination occurs by urine and fecal excretion.
▧ Half Life :
The elimination half-life of butorphanol is about 18 hours. In renally impaired patients with creatinine clearances <30 mL/min the elimination half-life is approximately doubled. After intravenous administration to patients with hepatic impairment, the elimination half-life of butorphanol was approximately tripled.
▧ Clearance :
* 99 +/- 23 L/h [Young with IV 2 mg]
* 82 +/- 21 [Eldery with IV 2 mg]